Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) shares were up 1,150% during trading on Friday . The company traded as high as $1.03 and last traded at $1.00. Approximately 46,500 shares changed hands during trading, an increase of 104% from the average daily volume of 22,784 shares. The stock had previously closed at $0.08.
Voyageur Pharmaceuticals Price Performance
The business has a 50-day moving average of $0.12 and a 200-day moving average of $0.10.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals, Inc is a biopharmaceutical company specializing in advanced drug-delivery technologies and contract development services. The company focuses on formulating and optimizing therapeutic compounds to enhance stability, bioavailability and controlled-release properties. By leveraging proprietary polymer- and lipid-based delivery platforms, Voyageur aims to partner with pharmaceutical and biotechnology firms to address formulation challenges in high-value therapeutic areas, including oncology, endocrinology and central nervous system disorders.
The company’s core offerings include formulation development, analytical testing, preclinical evaluation and small-scale manufacturing support.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
